PDPurnahamsi Desai

Purnahamsi Desai

*This is an algorithmically generated author record based on publicly available information.

Purnahamsi Desai has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Don’t wait, vaccinate: evaluation of routine vaccination administration and reactogenicity in preterm infants

    by Emily Abdelmessih, Purnahamsi V. Desai, Joanna Tracy, John Papadopoulos, Ferras Bashqoy

    Objective To evaluate the incidence of cardiorespiratory events in preterm infants when administering the 2-month vaccine series all at once compared to spreading vaccines over multiple days. Study design This single-center, retrospective cohort study from 2019–2022 included preterm neonates receiving 2-month vaccinations. The primary outcome was incidence of cardiorespiratory events from time of initial vaccine administration up to 48 h after final administration. Univariate analysis was performed to identify predictors of primary outcome. Results There were 127 patients (pre-practice change n1 = 52, post-practice change n2 = 75) included with no difference in the number of cardiorespiratory events between groups. Predictors of severe event included younger gestational age, smaller birth weight, shorter birth length, and greater cardiorespiratory events at baseline. Vaccine schedule interruptions occur more often when administration is spread over multiple days. Conclusion Administration of 2-month vaccinations all at once was not associated with increased cardiorespiratory events and prevents interruptions to vaccine schedule.


  • Open Access

    Don’t Wait, Vaccinate: Evaluation of Routine Immunization Administration and Reactogenecity in Preterm Infants

    by Ferras Bashqoy, Emily Abdelmessih, Purnahamsi Desai, Joanna Tracy, John Papadopoulos

    Objective: To evaluate the incidence of cardiorespiratory events in preterm infants when administering the 2-month vaccine series all at once compared to spreading vaccines over multiple days. Study Design: This single-center, retrospective cohort study from 2019-2022 included preterm neonates receiving 2-month immunizations. The primary outcome was incidence of cardiorespiratory events from time of initial vaccine administration up to 48 hours after final administration. Univariate analysis performed to identify predictors of primary outcome. Results: There were 127 patients (n1=52, n2=75) included. There was no difference in the number of cardiorespiratory events between groups. Predictors of severe event included younger gestational age, smaller birth weight, smaller birth length, and higher baseline apnea or bradycardia events at baseline. Vaccine schedule interruptions occur more often when administration is spread over multiple days. Conclusion: Administration of routine 2-month vaccinations all at once was not associated with increased cardiorespiratory events and prevents interruptions to vaccine schedule.

  • Open Access

    Virtual Care Across the Neonatal Intensive Care Continuum

    by Purnahamsi Desai, Sadaf H. Kazmi, Stacey Schneider, Robert Angert

    The ongoing coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for establishing effective parent and family engagement throughout all aspects of medicine. Though there has been some discussion in the literature regarding the transition from typical outpatient visits to telehealth visits, there has been less written about the inpatient approach to family inclusion. Here, we seek to describe our institution’s experience with implementing virtual medicine across the full continuum of the neonatal intensive care unit (NICU) experience, including inpatient rounding, child life family visits, and outpatient high-risk developmental follow-up after discharge.


  • Zoom Objective Structured Clinical Exams: Virtually the Same as the Real Thing?

    by Purnahamsi V. Desai, Heather B. Howell, Meaghan McGrath, Rachel Ramsey, Jonathan Lebowitz, Brit Trogen, Christine Cha, Kristyn A. Pierce, Sondra Zabar


  • Implementation and outcomes of a standard dose dextrose gel protocol for management of transient neonatal hypoglycemia

    by Purnahamsi Desai, Sourabh Verma, Sweta Bhargava, Marissa Rice, Joanna Tracy, Chanda Bradshaw

    Objective The use of oral dextrose gel (DG) reduces IV dextrose use. Prior studies used weight-based dosing (WD), though barriers exist, and are mitigated using standard dosing (SD). Our outcomes include IV dextrose use, NICU admissions, breastfeeding, adverse events, and assessment of WD vs SD. Study design Retrospective chart review comparing pre-DG, WD, and SD in 16490 newborns (1329 hypoglycemic) ≥ 35 weeks admitted to the nursery over 3 years. Results There was reduction in IV dextrose use 10.9% vs 6.5% (p = 0.004) and NICU admissions 27.9% vs 16.1% (p < 0.001) associated with DG use, and increased rate of breastfed infants 33.8% vs 43.5% (p = 0.001), with no difference between WD and SD. No difference noted in adverse events across the study period. Conclusions DG utilization is associated with reduced IV dextrose use, NICU admissions, and improved breastfeeding rates without changes in adverse events. We offer SD as a safe alternative to WD.


  • Neurodevelopmental outcomes of children with congenital heart disease: A review

    by Heather B. Howell, Michele Zaccario, Sadaf H. Kazmi, Purnahamsi Desai, Felice E. Sklamberg, Pradeep Mally


  • Higher Levels of a Cytotoxic Protein, Vaginolysin, in Lactobacillus-Deficient Community State Types at the Vaginal Mucosa

    by Rebecca G. Nowak, Tara M. Randis, Purnahamsi Desai, Xin He, Courtney K. Robinson, Jessica M. PhD Rath, Elbert D. Glover, Adam J. Ratner, Jacques Ravel, Rebecca M. Brotman

    Vaginolysin (VLY), a cytotoxic protein produced by Gardnerella vaginalis, may contribute to bacterial vaginosis. We observed that women with G. vaginalis, low levels of lactobacilli, history of vaginal douching, higher Nugent scores, and higher vaginal pH had increased VLY. Inflammatory markers were not highly expressed with increasing VLY. Vaginolysin's role in bacterial vaginosis warrants further evaluation.


  • Open Access

    Group B Streptococcus and the Vaginal Microbiota

    by Geoffrey H Rosen, Tara M Randis, Purnahamsi V Desai, Katherine J Sapra, Bing Ma, Pawel Gajer, Michael S Humphrys, Jacques Ravel, Shari E Gelber, Adam J Ratner

    Streptococcus agalactiae (group B Streptococcus [GBS]) is an important neonatal pathogen and emerging cause of disease in adults. The major risk factor for neonatal disease is maternal vaginal colonization. However, little is known about the relationship between GBS and vaginal microbiota. Vaginal lavage samples from nonpregnant women were tested for GBS, and amplicon-based sequencing targeting the 16S ribosomal RNA V3–V4 region was performed. Four hundred twenty-eight of 432 samples met the high-quality read threshold. There was no relationship between GBS carriage and demographic characteristics, α-diversity, or overall vaginal microbiota community state type (CST). Within the non-Lactobacillus-dominant CST IV, GBS positive status was significantly more prevalent in CST IV-A than CST IV-B. Significant clustering by GBS status was noted on principal coordinates analysis, and 18 individual taxa were found to be significantly associated with GBS carriage by linear discriminant analysis. After adjusting for race/ethnicity, 4 taxa were positively associated with GBS, and 6 were negatively associated. Vaginal microbiota CST and α-diversity are not related to GBS status. However, specific microbial taxa are associated with colonization of this important human pathogen, highlighting a potential role for the microbiota in promotion or inhibition of GBS colonization.


  • Open Access

    Vaginolysin Drives Epithelial Ultrastructural Responses to Gardnerella vaginalis

    by Tara M. Randis, Joanne Zaklama, Timothy J. LaRocca, Ferdinand C. O. Los, Emma L. Lewis, Purnahamsi Desai, Ryan Rampersaud, Fábio E. Amaral, Adam J. Ratner

    Gardnerella vaginalis , the bacterial species most frequently isolated from women with bacterial vaginosis (BV), produces a cholesterol-dependent cytolysin (CDC), vaginolysin (VLY). At sublytic concentrations, CDCs may initiate complex signaling cascades crucial to target cell survival. Using live-cell imaging, we observed the rapid formation of large membrane blebs in human vaginal and cervical epithelial cells (VK2 and HeLa cells) exposed to recombinant VLY toxin and to cell-free supernatants from growing liquid cultures of G. vaginalis . Binding of VLY to its human-specific receptor (hCD59) is required for bleb formation, as antibody inhibition of either toxin or hCD59 abrogates this response, and transfection of nonhuman cells (CHO-K1) with hCD59 renders them susceptible to toxin-induced membrane blebbing. Disruption of the pore formation process (by exposure to pore-deficient toxoids or pretreatment of cells with methyl-β-cyclodextrin) or osmotic protection of target cells inhibits VLY-induced membrane blebbing. These results indicate that the formation of functional pores drives the observed ultrastructural rearrangements. Rapid bleb formation may represent a conserved response of epithelial cells to sublytic quantities of pore-forming toxins, and VLY-induced epithelial cell membrane blebbing in the vaginal mucosa may play a role in the pathogenesis of BV.